Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00475501 · ClinicalTrials.gov registry record · Phase 2
5-Alpha Reductase and Anabolic Effects of Testosterone
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00475501: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT00475501 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00475501, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a higher-than-replacement dose of testosterone and finasteride can be combined to safely increase muscle strength in older men who have a low blood concentration of testosterone.
Interventions
- OTHER Placebo
- DRUG Finasteride
- DRUG Testosterone Enanthate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-01 |
| Est. Completion | 2014-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00475501
The ClinicalTrials.gov registry entry for NCT00475501 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00475501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00475501 about?
NCT00475501 is a clinical study titled "5-Alpha Reductase and Anabolic Effects of Testosterone". The purpose of this study is to determine whether a higher-than-replacement dose of testosterone and finasteride can be combined to safely increase muscle strength in older men who have a low blood concentration of testosterone.
What is the current status of trial NCT00475501?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2007-01. Estimated completion is 2014-10.
What interventions are being tested in trial NCT00475501?
The interventions under investigation include: Placebo (OTHER), Finasteride (DRUG), Testosterone Enanthate (DRUG).
Who is sponsoring clinical trial NCT00475501?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.